Nuvation Bio Draws Attention with Strong Results in Lung Cancer Therapy

Nuvation Bio focuses on the development of novel cancer therapies, particularly targeting hard-to-treat tumors. The company is working on several drug candidates that aim to specifically intervene in central growth and resistance mechanisms of tumor cells. These include inhibitors that address specific gene mutations, as well as compounds that target epigenetic vulnerabilities. Nuvation Bio's strategy aims to make progress where conventional treatments reach their limits, providing patients with options that have been scarcely available until now....